Dispatch Bio: Valuation, Funding & Investors
https://dispatchbio.com/Therapeutics
Dispatch Bio is a private biotechnology company engaged in the discovery and development of novel therapeutic candidates and associated delivery technologies for human disease. The company focuses on translating early-stage biological research into preclinical and clinical programs and collaborates with research institutions and industry partners to advance its pipeline.
Leadership & Board
- Current Number of Employees
- 74
- Current LinkedIn Followers
- 8,369
Latest Estimated Valuation
- Total Amount Raised
- $216M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $216M
- Latest Funding Round
- Series A
Employee Trend
Dispatch Bio had 74 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
74Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Dispatch Bio had 8,369 followers as of October 26, 2026. The number of followers increased by 46 (0.55%) week-over-week.
8,369Latest Followers Count
46(0.55%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 23, 2025 | Series A | $216.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ARCH Venture Partners | Series A |
Similar Companies
A snapshot of private companies similar to Dispatch Bio, helping you discover and navigate related company profiles.
Related News and Analysis
